{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:38:37Z","timestamp":1760236717642,"version":"build-2065373602"},"reference-count":108,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>There have been several reported cases of severe acute respiratory syndrome (SARS-CoV-2) infection that were associated with an increased incidence of neurological manifestations, including Guillain\u2013Barr\u00e9 syndrome (GBS). This review aims to present information on the reports of GBS associated with coronavirus disease 2019 (COVID-19) infection. Our review is retrospective work examining articles published from the 1 April 2020 to the 8 May 2021 in the English language. We used the diagnostic criteria and classification published by the National Institute of Neurological Disorders and Stroke and Brighton Collaboration. GBS is usually a postinfectious syndrome, but GBS in the COVID-19 pandemic also takes on a para-infectious profile. In the reports, the genetic factor has a role in developing GBS in some patients. In conclusion, the association between COVID-19 and GBS is not very clear. Still, one mechanism is strongly associated with COVID-19 and immune-mediated neurological complications, which is molecular mimicry between SARS-CoV-2 and human autoantigens.<\/jats:p>","DOI":"10.3390\/neurolint14010003","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T01:06:54Z","timestamp":1640567214000},"page":"34-48","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Guillain-Barr\u00e9 Syndrome in the COVID-19 Pandemic"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-2411","authenticated-orcid":false,"given":"Abdullah Ahmad","family":"Tawakul","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Medicine, Umm Al Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-1514","authenticated-orcid":false,"given":"Amal Waleed","family":"Al-Doboke","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-4646","authenticated-orcid":false,"given":"Shahad Ali","family":"Altayyar","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9521-7154","authenticated-orcid":false,"given":"Seham Abdulhafith","family":"Alsulami","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9511-9415","authenticated-orcid":false,"given":"Ahlam Musallam","family":"Alfahmi","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghad Turki","family":"Nooh","sequence":"additional","affiliation":[{"name":"College of Medicine, Umm Al-Qura University, Al-Abdia Main Campus, Makkah 21955, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular Presentations in Patients with COVID-19","volume":"41","author":"Paliwal","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pennisi, M., Lanza, G., Falzone, L., Fisicaro, F., Ferri, R., and Bella, R. (2020). Sars-Cov-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155475"},{"key":"ref_3","unstructured":"(2021, September 10). Countries Where Coronavirus Has Spread\u2014Worldometer. Available online: https:\/\/www.worldometers.info\/coronavirus\/countries-where-coronavirus-has-spread\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.00909","article-title":"COVID-19 and Guillain\u2013Barr\u00e9 Syndrome: A Case Report and Review of Literature","volume":"11","author":"Zito","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19\u2013Associated Guillain-Barr\u00e9 Syndrome: The Early Pandemic Experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"175628642093203","DOI":"10.1177\/1756286420932036","article-title":"Neurological Manifestations and Implications of COVID-19 Pandemic","volume":"13","author":"Tsivgoulis","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmi.2020.11.005","article-title":"Neurologic Manifestations Associated with COVID-19: A Multicentre Registry","volume":"27","author":"Meppiel","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","first-page":"1","article-title":"Guillain-Barre Syndrome during COVID-19 Pandemic: An Overview of the Reports","volume":"41","author":"Rahimi","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","article-title":"Guillain-Barr\u00e9 Syndrome in SARS-CoV-2 Infection: An Instant Systematic Review of the First Six Months of Pandemic","volume":"91","author":"Uncini","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and Management of Guillain\u2013Barr\u00e9 Syndrome in Ten Steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e236419","DOI":"10.1136\/bcr-2020-236419","article-title":"Miller Fisher Syndrome and COVID-19: Is There a Link","volume":"13","author":"Ray","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e239218","DOI":"10.1136\/bcr-2020-239218","article-title":"Guillain-Barr\u00e9 Syndrome after COVID-19 in Japan","volume":"13","author":"Hirayama","year":"2020","journal-title":"Bmj Case Rep."},{"key":"ref_14","first-page":"e601","article-title":"Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19","volume":"95","year":"2020","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jocn.2020.05.016","article-title":"Facial Diplegia, a Possible Atypical Variant of Guillain-Barr\u00e9 Syndrome as a Rare Neurological Complication of SARS-CoV-2","volume":"77","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.supp.2020.35.2.25745","article-title":"Acute Guillain-Barr\u00e9 Polyradiculoneuritis Indicative of COVID-19 Infection: A Case Report","volume":"35","author":"Atakla","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"ref_17","first-page":"1351","article-title":"Early Guillain-Barr\u00e9 Syndrome in Coronavirus Disease 2019 (COVID-19): A Case Report from an Italian COVID-Hospital","volume":"41","author":"Ottaviani","year":"2020","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13365-020-00884-7","article-title":"Severe Rapidly Progressive Guillain-Barr\u00e9 Syndrome in the Setting of Acute COVID-19 Disease","volume":"26","author":"Abrams","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"McDonnell, E.P., Altomare, N.J., Parekh, Y.H., Gowda, R.C., Parikh, P.D., Lazar, M.H., and Blaser, M.J. (2020). COVID-19 as a Trigger of Recurrent Guillain\u2013Barr\u00e9 Syndrome. Pathogens, 9.","DOI":"10.3390\/pathogens9110965"},{"key":"ref_20","first-page":"100013","article-title":"Guillain-Barre Syndrome Following Covid-19 in Patient with Breast Cancer-A Case Presentation and Review of the Literature","volume":"5","author":"Alpert","year":"2021","journal-title":"J. Cell Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"602554","DOI":"10.3389\/fneur.2020.602554","article-title":"Case Report: Postacute Rehabilitation of Guillain-Barr\u00e9 Syndrome and Cerebral Vasculitis-Like Pattern Accompanied by SARS-CoV-2 Infection","volume":"11","author":"Colonna","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"106413","DOI":"10.1016\/j.clineuro.2020.106413","article-title":"Guillain-Barre Syndrome and COVID-19: A Case Report","volume":"200","author":"Bueso","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_23","first-page":"e14161","article-title":"Guillain-Barre Syndrome in a Patient With Asymptomatic Coronavirus Disease 2019 Infection and Major Depressive Disorder","volume":"13","author":"Mokhashi","year":"2021","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/j.jinf.2020.05.057","article-title":"Qualitative Serology in Patients Recovered from SARS CoV 2 Infection","volume":"81","author":"Bettencourt","year":"2020","journal-title":"J. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajem.2020.09.029","article-title":"Covid-19 Associated Guillain-Barre Syndrome: Contrasting Tale of Four Patients from a Tertiary Care Centre in India","volume":"39","author":"Nanda","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s13760-020-01421-3","article-title":"Facing Acute Neuromuscular Diseases during COVID-19 Pandemic: Focus on Guillain\u2013Barr\u00e9 Syndrome","volume":"120","author":"Galassi","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"ref_27","first-page":"251","article-title":"Novel Coronavirus (COVID-19)-Associated Guillain\u2013Barre\u2019 Syndrome: Case Report","volume":"14","author":"Mantefardo","year":"2021","journal-title":"Int. Med. Case Rep. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jocn.2020.11.013","article-title":"Guillain\u2013Barr\u00e9 Syndrome as a Parainfectious Manifestation of SARS-CoV-2 Infection: A Case Series","volume":"83","author":"Abolmaali","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"ref_29","first-page":"e11326","article-title":"Mesenteric Artery Thrombosis, Microvascular Intestinal Endothelitiis, and Guillain-Barr\u00e8 Syndrome in the Same SARS-CoV-2 Patient","volume":"12","author":"Ferraris","year":"2020","journal-title":"Cureus"},{"key":"ref_30","first-page":"e12424","article-title":"Miller Fisher Syndrome in the COVID-19 Era \u2013 A Novel Target Antigen Calls for Novel Treatment","volume":"13","author":"Kajani","year":"2021","journal-title":"Cureus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103172","DOI":"10.1016\/j.ijoa.2021.103172","article-title":"Guillain-Barr\u00e9 Syndrome in the Early Post-Partum Period Following COVID-19 Infection","volume":"47","author":"Abdelnasser","year":"2021","journal-title":"Int. J. Obstet. Anesth."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp-2019-321890","article-title":"Hyper-Reflexia in Guillain-Barr\u00e9 Syndrome: Systematic Review","volume":"91","author":"Uncini","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 Syndrome: Molecular Mimicry with Human Heat Shock Proteins as Potential Pathogenic Mechanism","volume":"25","author":"Lucchese","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0022-510X(99)00173-2","article-title":"Clinical Presentation and Outcome of Guillain-Barr\u00e9 and Related Syndromes in Relation to Anti-Ganglioside Antibodies","volume":"168","author":"Carpo","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42399-020-00646-w","article-title":"COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-Infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications","volume":"2","author":"Kajumba","year":"2020","journal-title":"Sn Compr. Clin. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"117316","DOI":"10.1016\/j.jns.2021.117316","article-title":"Cerebrospinal Fluid in COVID-19: A Systematic Review of the Literature","volume":"421","author":"Lewis","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2004.045336","article-title":"Factors Influencing PCR Detection of Viruses in Cerebrospinal Fluid of Patients with Suspected CNS Infections","volume":"76","author":"Davies","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2020-323522","article-title":"Status of SARS-CoV-2 in Cerebrospinal Fluid of Patients with COVID-19 and Stroke","volume":"91","author":"Ghosh","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbi.2020.05.002","article-title":"SARS-CoV-2: \u201cThree-Steps\u201d Infection Model and CSF Diagnostic Implication","volume":"87","author":"Panciani","year":"2020","journal-title":"BrainBehav. Immun."},{"key":"ref_40","first-page":"1843","article-title":"Detection of SARS-CoV-2 in Different Types of Clinical Specimens","volume":"323","author":"Wang","year":"2020","journal-title":"Jama J. Am. Med. Assoc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00415-020-09911-3","article-title":"Guillain-Barr\u00e9 Syndrome in the COVID-19 Era: Just an Occasional Cluster?","volume":"268","author":"Gigli","year":"2021","journal-title":"J. Neurol."},{"key":"ref_42","unstructured":"(2021, October 30). Guillain-Barre Syndrome: Practice Essentials, Background, Pathophysiology. Available online: https:\/\/emedicine.medscape.com\/article\/315632-overview#a4."},{"key":"ref_43","unstructured":"CDC (2021, September 10). What You Need to Know about Variants, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant.html."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e00815","DOI":"10.1016\/j.idcr.2020.e00815","article-title":"Symmetrical Polyneuropathy in Coronavirus Disease 2019 (COVID-19)","volume":"21","author":"Ghiasvand","year":"2020","journal-title":"IDCases"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 Syndrome Associated with SARS-CoV-2 Infection: Causality or Coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre Syndrome Associated with COVID-19 Infection: A Case Report","volume":"76","author":"Sedaghat","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2020.04.074","article-title":"Guillain-Barr\u00e9 Syndrome as a Complication of SARS-CoV-2 Infection","volume":"87","author":"Coen","year":"2020","journal-title":"BrainBehav. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jns.12382","article-title":"Guillain-Barr\u00e9 Syndrome during SARS-CoV-2 Pandemic: A Case Report and Review of Recent Literature","volume":"25","author":"Scheidl","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CND.0000000000000309","article-title":"Novel Coronavirus (COVID-19)-Associated Guillain\u2013Barr\u00e9 Syndrome: Case Report","volume":"21","author":"Rana","year":"2020","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_50","first-page":"E54","article-title":"Guillain\u2013Barr\u00e9 Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection","volume":"62","author":"Ozpar","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/ene.14383","article-title":"Miller-Fisher Syndrome after SARS-CoV-2 Infection","volume":"27","author":"Urbaneja","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13365-020-00858-9","article-title":"Miller Fisher Syndrome Diagnosis and Treatment in a Patient with SARS-CoV-2","volume":"26","author":"Manganotti","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/ene.14398","article-title":"Guillain-Barr\u00e9 Syndrome after SARS-CoV-2 Infection","volume":"27","author":"Kilinc","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/ene.14388","article-title":"Guillain-Barr\u00e9 Syndrome in a Patient with Antibodies against SARS-COV-2","volume":"27","author":"Helbok","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e236182","DOI":"10.1136\/bcr-2020-236182","article-title":"Guillain-Barr\u00e9 Syndrome Following COVID-19: A Newly Emerging Post-Infectious Complication","volume":"13","author":"Webb","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-020-10014-2","article-title":"Acute Inflammatory Demyelinating Polyneuritis in Association with an Asymptomatic Infection by SARS-CoV-2","volume":"267","author":"Bracaglia","year":"2020","journal-title":"J. Neurol."},{"key":"ref_57","first-page":"1","article-title":"Guillain-Barr\u00e9 Syndrome and SARS-CoV-2","volume":"2","author":"Lampe","year":"2020","journal-title":"Neurol. Res. Pr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e236536","DOI":"10.1136\/bcr-2020-236536","article-title":"Guillain-Barr\u00e9 Syndrome Associated with COVID-19 Infection: A Case from the UK","volume":"13","author":"Tiet","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","article-title":"Is Guillain-Barr\u00e8 Syndrome Triggered by SARS-CoV-2? Case Report and Literature Review","volume":"42","author":"Agosti","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.7861\/clinmed.2020-0213","article-title":"Guillain\u2013Barr\u00e9 Syndrome Associated with Leptomeningeal Enhancement Following SARS-CoV-2 Infection","volume":"20","author":"Garay","year":"2020","journal-title":"Clin. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajem.2020.07.074","article-title":"Guillain-Barr\u00e9 Syndrome in a Patient Previously Diagnosed with COVID-19","volume":"45","author":"Defabio","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.nmd.2020.08.354","article-title":"Guillain-Barr\u00e9-Strohl Syndrome and COVID-19: Case Report and Literature Review","volume":"30","author":"Gil","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_63","first-page":"1707","article-title":"COVID-19\u2013Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barr\u00e9 Syndrome","volume":"41","author":"Hutchins","year":"2020","journal-title":"Am. J. Neuroradiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00415-020-10219-5","article-title":"A Rare Case of Acute Motor Axonal Neuropathy and Myelitis Related to SARS-CoV-2 Infection","volume":"268","author":"Barra","year":"2021","journal-title":"J. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e236978","DOI":"10.1136\/bcr-2020-236978","article-title":"Case Report: Guillain-Barr\u00e9 Syndrome Presenting with COVID-19 Infection","volume":"13","author":"Ameer","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02162-3","article-title":"Concomitant Guillain-Barre Syndrome with COVID-19: A Case Report","volume":"21","author":"Mackenzie","year":"2021","journal-title":"BMC Neurol."},{"key":"ref_67","first-page":"e13828","article-title":"Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review","volume":"13","author":"Singh","year":"2021","journal-title":"Cureus"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e927956-1","DOI":"10.12659\/AJCR.927956","article-title":"A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barr\u00e9 Syndrome and Bell\u2019s Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin","volume":"21","author":"Khaja","year":"2020","journal-title":"Am. J. Case Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"237215","DOI":"10.1136\/bcr-2020-237215","article-title":"Case Report: Guillain-Barr\u00e9 Syndrome Associated with COVID-19 Disease","volume":"13","author":"Korem","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"240178","DOI":"10.1136\/bcr-2020-240178","article-title":"Late Onset of Guillain-Barr\u00e9 Syndrome Following SARS-CoV-2 Infection: Part of \u2018Long COVID-19 Syndrome\u2019?","volume":"14","author":"Raahimi","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_71","first-page":"1","article-title":"Peculiar Presentation of COVID-19: A Case Report of Concurrent Stroke and Guillain\u2013Barr\u00e9 Syndrome","volume":"2021","author":"Ansari","year":"2021","journal-title":"Case Rep. Neurol. Med."},{"key":"ref_72","first-page":"e13096","article-title":"Guillain-Barre Syndrome Associated With COVID-19 Infection: A Case Report With Review of Literature","volume":"13","author":"Meshref","year":"2021","journal-title":"Cureus"},{"key":"ref_73","first-page":"1264","article-title":"Intravenous Immunoglobulin May Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain\u2013Barr\u00e9 Syndrome","volume":"24","author":"Chakraborty","year":"2020","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jocn.2021.01.028","article-title":"Guillain Barre Syndrome Following Delivery in a Pregnant Woman Infected with SARS-CoV-2","volume":"86","author":"Tekin","year":"2021","journal-title":"J. Clin. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.12691\/ajmcr-9-3-16","article-title":"Guillain-Barr\u00e9 Syndrome in a COVID-19 Patient: A Case Report and Review of Management Strategies","volume":"9","author":"Mostel","year":"2021","journal-title":"Am. J. Med. Case Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-021-02831-4","article-title":"Acute Inflammatory Demyelinating Polyneuropathy or Guillain-Barr\u00e9 Syndrome Associated with COVID-19: A Case Report","volume":"15","author":"Gagarkin","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"ref_77","first-page":"1","article-title":"Guillain-Barr\u00e9 Syndrome after Novel Coronavirus Disease 2019","volume":"15","author":"Yakoby","year":"2021","journal-title":"J. Emerg. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"577590","DOI":"10.1016\/j.jneuroim.2021.577590","article-title":"Guillain-Barr\u00e9 Syndrome Associated with SARS-CoV-2 Infection: A Case Report with Long Term Follow Up","volume":"356","author":"Papri","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2478\/jccm-2020-0038","article-title":"Atypical Variant of Guillain Barre Syndrome in a Patient with COVID-19","volume":"6","author":"Lowery","year":"2020","journal-title":"J. Crit. Care Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10072-020-04787-7","article-title":"HLA and Immunological Features of SARS-CoV-2-Induced Guillain-Barr\u00e9 Syndrome","volume":"41","author":"Gigli","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e112645","DOI":"10.5812\/jjcmb.112645","article-title":"Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report","volume":"12","author":"Shaliahmadi","year":"2021","journal-title":"Jentashapir J. Cell. Mol. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"659","DOI":"10.14260\/jemds\/2021\/141","article-title":"Para Infectious Guillain-Barre Syndrome [GBS) in Covid-19 A Case Report","volume":"10","author":"Lahole","year":"2021","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"ref_83","first-page":"usab158","article-title":"Guillain\u2013Barre Syndrome Associated With COVID-19 Pneumonia\u2014The First Documented Case in a U.S. Military Intensive Care Unit","volume":"2021","author":"Yiu","year":"2021","journal-title":"Mil. Med."},{"key":"ref_84","first-page":"683","article-title":"Unusual Presentation of COVID-19 Disease Leading to Respiratory Distress and Coma","volume":"77","author":"Paradis","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000513382","article-title":"Guillain-Barre Syndrome Following COVID-19 Infection: First Case Report from Kuwait and Review of the Literature","volume":"4","author":"Kamel","year":"2021","journal-title":"Dubai Med. J."},{"key":"ref_86","first-page":"1","article-title":"Annals of Clinical and Medical Case Reports Guillain Barre Syndrome & Covid-19: A Case Report Citation: Charra, B. Guillain Barre Syndrome & Covid-19: A Case Report","volume":"5","author":"Charra","year":"2019","journal-title":"Ann. Clin. Med. Case Rep."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Bastug, A., Universitesi, S.B., Bektas, H., and Buyuktarakci, C. (2021). Parainfectious Guillain Barre Syndrome in a Patient Diagnosed with COVID-19.","DOI":"10.21203\/rs.3.rs-215097\/v1"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00415-021-10417-9","article-title":"COVID-19-Induced Exacerbation of Chronic Inflammatory Demyelinating Polyneuropathy","volume":"268","author":"Veenker","year":"2021","journal-title":"J. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.bbih.2021.100203","article-title":"GM1 Ganglioside Antibody and COVID-19 Related Guillain Barre Syndrome\u2014A Case Report, Systemic Review and Implication for Vaccine Development","volume":"12","author":"Dufour","year":"2021","journal-title":"BrainBehav. Immun. Health"},{"key":"ref_90","first-page":"e00771","article-title":"Guillain-Barr\u00e9 Syndrome Associated with SARS-CoV-2 Infection","volume":"20","author":"Virani","year":"2020","journal-title":"ID Cases"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Porro, P., Valenzuela-Chamorro, S., Cabal-Paz, B., Ochoa-L\u00f3pez, C., Garc\u00eda-Fleitas, B., Ebrat-Mancilla, E., Novo-Ponte, S., and Gonz\u00e1lez-Santiago, R. (2020). A Case of Guillain-Barr\u00e9 Syndrome Following Coronavirus Disease 2019. Neurol. Clin. Pract.","DOI":"10.1212\/CPJ.0000000000000917"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Sidig, A., Abbasher, K., Digna, M.F., Elsayed, M., Abbasher, H., and Abbasher, M. (2020). COVID-19 and Guillain-Barre Syndrome-a Case Report. 6, 1\u20133.","DOI":"10.21203\/rs.3.rs-48327\/v1"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Mackenzie, N., Lopez-Coronel, E., Alberto Dau, C., Mattar, S., Tapia Garcia, J., Cristina Lanata Rosalind Russell, C., Engleman, E.P., and Felipe Guillen-Burgos, H. (2020). A Concomitant Guillain-Barre Syndrome with COVID-19: A First Case-Report in Colombia. 21, 135.","DOI":"10.21203\/rs.3.rs-61279\/v1"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"A771","DOI":"10.1016\/j.chest.2020.08.718","article-title":"A unique case of guillain-barr\u00e9 syndrome related to COVID-19 infection","volume":"158","author":"Yaqoob","year":"2020","journal-title":"Chest"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"A512","DOI":"10.1016\/j.chest.2020.08.488","article-title":"Guillain-barr\u00e9 syndrome in the setting of COVID-19 infection","volume":"158","author":"Mallari","year":"2020","journal-title":"Chest"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"A522","DOI":"10.1016\/j.chest.2020.08.496","article-title":"COVID-19 infection complicated by Guillain-Barr\u00e9 syndrome: A case report","volume":"158","author":"Bueso","year":"2020","journal-title":"Chest"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.medcli.2020.06.023","article-title":"Guillain-Barr\u00e9 Syndrome after Covid-19 Infection","volume":"155","year":"2020","journal-title":"Med. Clin."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neucli.2020.09.007","article-title":"Anti-Pan-Neurofascin IgM in COVID-19-Related Guillain-Barr\u00e9 Syndrome: Evidence for a Nodo-Paranodopathy","volume":"50","author":"Tard","year":"2020","journal-title":"Neurophysiol. Clin."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sharma, R., Sardar, S., Iqbal, P., Ameen, A., Adeli, G.A., Sadik, N., and Elzouki, A.-N. (2021). COVID-19-Associated Acute Motor Axonal Neuropathy, a Variant of Guillain-Barr\u00e9 Syndrome: Expanding the Neurological Manifestations of SARS-CoV-2. Authorea Prepr.","DOI":"10.22541\/au.161282652.24050068\/v1"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"100739","DOI":"10.1016\/j.gore.2021.100739","article-title":"Guillain-Barre Syndrome in a Patient with Uterine Adenocarcinoma Undergoing Treatment with Immune-Checkpoint Inhibitor Therapy: A Case Report and Review of the Literature","volume":"36","author":"Brzezinska","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_101","first-page":"A2472","article-title":"Guillain-Barre Syndrome Related to Coronavirus Disease-2019 (COVID-19) Infection","volume":"2019","author":"Rahi","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_102","first-page":"A4071","article-title":"Guillain-Barre Syndrome Secondary to SARS-CoV-2","volume":"203","author":"Chaudhary","year":"2021","journal-title":"Am. Thorac. Soc. Int. Conf. Meet. Abstr. Am. Thorac. Soc. Int. Conf. Meet. Abstr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1007\/s00415-021-10515-8","article-title":"Could Symptom Overlap of COVID-19 and Guillain\u2013Barr\u00e9 Syndrome Mask an Epidemiological Association?","volume":"268","author":"Kohle","year":"2021","journal-title":"J. Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s42399-021-00855-x","article-title":"Acute Polyneuropathy in an Outpatient Context During the SARS-CoV-2 Pandemic: A Brief Case Serie Report","volume":"3","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"ref_105","first-page":"e12695","article-title":"Guillain-Barr\u00e9 Syndrome as a Complication of COVID-19","volume":"13","author":"Zubair","year":"2021","journal-title":"Cureus"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jmv.26289","article-title":"Clinical Neurophysiology and Cerebrospinal Liquor Analysis to Detect Guillain-Barr\u00e9 Syndrome and Polyneuritis Cranialis in COVID-19 Patients: A Case Series","volume":"93","author":"Manganotti","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s10072-020-04484-5","article-title":"New Clinical Manifestation of COVID-19 Related Guillain-Barr\u00e8 Syndrome Highly Responsive to Intravenous Immunoglobulins: Two Italian Cases","volume":"41","author":"Assini","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1212\/CPJ.0000000000000880","article-title":"A Case Series of Guillain-Barr\u00e9 Syndrome After COVID-19 Infection in New York","volume":"11","author":"Chan","year":"2021","journal-title":"Neurol. Clin. Pract."}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/14\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:52:31Z","timestamp":1760169151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/14\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["neurolint14010003"],"URL":"https:\/\/doi.org\/10.3390\/neurolint14010003","relation":{},"ISSN":["2035-8377"],"issn-type":[{"type":"electronic","value":"2035-8377"}],"subject":[],"published":{"date-parts":[[2021,12,24]]}}}